|
|
|
|
LEADER |
01281nom a2200373 u 4500 |
001 |
10090750 |
003 |
upatras |
005 |
20210117202827.0 |
008 |
110802s2010 eng |
020 |
|
|
|a 9781603272711
|
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
100 |
1 |
|
|a Polunovsky, Vitaly A
|9 94561
|
245 |
1 |
0 |
|a mTOR Pathway and mTOR Inhibitors in Cancer Therapy
|h [electronic resource]
|c edited by Vitaly A. Polunovsky, Peter J. Houghton
|
250 |
|
|
|a First
|
260 |
|
|
|a Totowa, NJ
|b Springer Science+Business Media, LLC
|c 2010
|
300 |
|
|
|b v.: digital
|
490 |
0 |
|
|a Cancer Drug Discovery and Development
|
650 |
|
4 |
|a Medicine
|9 11026
|
650 |
|
4 |
|a Oncology
|9 64093
|
650 |
|
4 |
|a Toxicology
|9 13539
|
650 |
|
4 |
|a Cytology
|9 10173
|
650 |
|
4 |
|a Biomedicine
|9 64032
|
650 |
|
4 |
|a Cancer Research
|9 64095
|
650 |
|
4 |
|a Cell Biology
|9 15406
|
650 |
|
4 |
|a Pharmacology/Toxicology
|9 64073
|
700 |
1 |
|
|a Houghton, Peter J
|9 94383
|
710 |
2 |
|
|a SpringerLink (Online service)
|9 68735
|
760 |
1 |
|
|a Cancer Drug Discovery and Development
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-60327-271-1
|
942 |
|
|
|2 ddc
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 98664
|a LISP
|b LISP
|d 2016-04-24
|l 0
|r 2016-04-24 00:00:00
|w 2016-04-24
|y ERS
|
999 |
|
|
|c 66450
|d 66450
|